*Result*: Enhancing Alzheimer's disease classification with a transformer-based model using self-supervised learning.
Bioengineering (Basel). 2023 Oct 20;10(10):. (PMID: 37892955)
Comput Biol Med. 2024 Sep;179:108874. (PMID: 39013343)
JMIR Med Inform. 2024 Nov 18;12:e49724. (PMID: 39556827)
Sensors (Basel). 2023 Jul 31;23(15):. (PMID: 37571619)
IEEE J Biomed Health Inform. 2024 Nov 18;PP:. (PMID: 40030239)
Front Neurosci. 2025 Sep 26;19:1623141. (PMID: 41079483)
Sensors (Basel). 2020 Dec 31;21(1):. (PMID: 33396415)
Nat Commun. 2024 Oct 25;15(1):9235. (PMID: 39455566)
IEEE Trans Med Imaging. 2023 Feb;42(2):391-402. (PMID: 36018878)
J Med Syst. 2024 Feb 17;48(1):23. (PMID: 38367119)
Bioengineering (Basel). 2023 Sep 28;10(10):. (PMID: 37892871)
Neuroimage. 2024 Aug 15;297:120737. (PMID: 39004409)
Med Image Comput Comput Assist Interv. 2022 Sep;13431:461-470. (PMID: 38680538)
Sensors (Basel). 2023 Feb 03;23(3):. (PMID: 36772733)
Sci Rep. 2025 Aug 8;15(1):29038. (PMID: 40781125)
Comput Biol Med. 2023 Sep;164:107328. (PMID: 37573721)
Comput Med Imaging Graph. 2025 Oct;125:102621. (PMID: 40857849)
IEEE/ACM Trans Comput Biol Bioinform. 2024 Nov-Dec;21(6):1830-1841. (PMID: 38954584)
Bioengineering (Basel). 2025 Oct 15;12(10):. (PMID: 41155106)
IEEE Trans Pattern Anal Mach Intell. 2013 Aug;35(8):1798-828. (PMID: 23787338)
*Further Information*
*Alzheimer's disease (AD) is a progressive neurodegenerative disease and the current diagnosis tools, which are used, including clinical examination and neuroimaging, are costly, time consuming and complicated to generalize across demographics. Traditional machine learning (ML) methods such as Support Vector Machines (SVM), LightGBM, and Random Forest (RF) are known to be having weakness in terms of feature selection, class imbalance, and generalization. This paper presents a new Enhanced TabTransformer with Self-Supervised Learning (ETT-SSL) framework of AD classification. The structure combines the transformer-based architecture, self-supervised learning (SSL) for feature representation, SHAP-based feature selection, and the use of SMOTE to balance classes. Experimental results also indicate that ETT-SSL reaches a high accuracy of 95.8%, which is a much better result than baseline models (SVM: 72.1, RF: 78.3, LightGBM: 80.5) and even the standard TabTransformer (85.2%). Additionally, ETT-SSL offers greater accuracy and improved recall, overcoming the issue of false negatives in AD diagnosis. SHAP analysis can be used to improve transparency in clinical decision-making by making use of the model interpretability. The proposed framework recommends a salivary, interpretability and clinically practical methodology that can be used to expand to multimodal data source (e.g. MRI scans, genomic markers and electronic health records) to improve accuracy and generalisability.
(© 2025. The Author(s).)*
*Declarations. Competing interests: The authors declare no competing interests.*